Annu Rev Physiol 79(1):425448
Dose, duration, adherence, and changes in other medications over time are also important unanswered issues. Researchers say randomized clinical trials will be needed to confirm the findings and better understand how GLP-1 medications may affect cardiovascular risk in people with autoimmune diseases
Optimizes insulin release: Helps the pancreas release insulin only when needed (after meals), while reducing glucagonthe hormone that raises blood sugar
Redness, warmth, increasing firmness, or persistent bruising beyond 3 days may indicate lipohypertrophy or infection
Targeting Fat Loss While Preserving Muscle Mass Introducing Our Biotech Watchlist: High-Impact Drugs to Follow Welcome to the first edition of this newsletter series, where we spotlight breakthrough therapieswhether in development or already on the marketthat we believe could be game-changers for both patients and investors